EUVIMEDEUVIMED entdecken
Open Access

Enterovirus evolution reveals the mechanism of an RNA-targeted antiviral and determinants of viral replication

Jesse Davila-Calderon iD, Mei-Ling Li iD, Srinivasa R Penumutchu, Christina Haddad iD, Linzy Malcolm iD, Josephine King iD, Amanda E Hargrove iD, Gary Brewer iD, Blanton S Tolbert iD

Science Advances · 2024

DOI: 10.1126/sciadv.adg3060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Jesse Davila-Calderon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Case Western Reserve University, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Enterovirus, Enterovirus A, Human, Enterovirus Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Selective pressures on viruses provide opportunities to establish target site specificity and mechanisms of antivirals. Enterovirus (EV)-A71 with resistant mutations in the stem loop (SL) II internal ribosome entry site (IRES) (SLII resist ) were selected at low doses of the antiviral dimethylamiloride (DMA)-135. The EV-A71 mutants were resistant to DMA-135 at concentrations that inhibit replication of wild-type virus. EV-A71 IRES structures harboring resistant mutations induced efficient expression of Luciferase messenger RNA in the presence of noncytotoxic doses of DMA-135. Nuclear magnetic resonance indicates that the mutations change the structure of SLII at the binding site of DMA-135 and at the surface recognized by the host protein AU-rich element/poly(U)-binding/degradation factor 1 (AUF1). Biophysical studies of complexes formed between AUF1, DMA-135, and either SLII or SLII resist show that DMA-135 stabilizes a ternary complex with AUF1-SLII but not AUF1-SLII resist . This work demonstrates how viral evolution elucidates the (DMA-135)–RNA binding site specificity in cells and provides insights into the viral pathways inhibited by the antiviral.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EnterovirusEnterovirus A, HumanEnterovirus InfectionsHumansVirus ReplicationAntigens, ViralRNA, ViralAntiviral Agents

Substanzen

Antigens, ViralRNA, ViralAntiviral Agents

Autor:innen und Institutionen

  • Department of Chemistry, Case Western Reserve University, Cleveland, OH, USA.
  • Department of Biochemistry and Molecular Biology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, USA.
  • Department of Chemistry, Duke University, Durham, NC, USA.
  • Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.
  • Howard Hughes Medical Institute, Chevy Chase, MD, USA.

ORCID-Profile: Jesse Davila-Calderon, Mei-Ling Li, Christina Haddad, Linzy Malcolm, Josephine King, Amanda E Hargrove, Gary Brewer, Blanton S Tolbert

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Davila-Calderon, J., Li, M. L., Penumutchu, S. R., Haddad, C., Malcolm, L., King, J., Hargrove, A. E., Brewer, G., & Tolbert, B. S. (2024). Enterovirus evolution reveals the mechanism of an RNA-targeted antiviral and determinants of viral replication. Science Advances. https://doi.org/10.1126/sciadv.adg3060

Vancouver

Davila-Calderon J, Li ML, Penumutchu SR, Haddad C, Malcolm L, King J, et al. Enterovirus evolution reveals the mechanism of an RNA-targeted antiviral and determinants of viral replication. Science Advances. 2024. doi:10.1126/sciadv.adg3060

BibTeX
@article{DavilaCalderon2024,
  author = {Davila-Calderon, Jesse and Li, Mei-Ling and Penumutchu, Srinivasa R and Haddad, Christina and Malcolm, Linzy and King, Josephine and Hargrove, Amanda E and Brewer, Gary and Tolbert, Blanton S},
  title = {Enterovirus evolution reveals the mechanism of an RNA-targeted antiviral and determinants of viral replication},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adg3060}
}
Kostenlos starten →